These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 23410183

  • 1. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes.
    Han D, Yamamoto Y, Munesue S, Motoyoshi S, Saito H, Win MT, Watanabe T, Tsuneyama K, Yamamoto H.
    Genes Cells; 2013 Apr; 18(4):302-14. PubMed ID: 23410183
    [Abstract] [Full Text] [Related]

  • 2. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
    Garris DR, Garris BL.
    Pathobiology; 2004 Apr; 71(5):231-40. PubMed ID: 15459481
    [Abstract] [Full Text] [Related]

  • 3. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus.
    Lim M, Park L, Shin G, Hong H, Kang I, Park Y.
    Ann N Y Acad Sci; 2008 Dec; 1150():311-5. PubMed ID: 19120318
    [Abstract] [Full Text] [Related]

  • 4. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes.
    Wendt T, Harja E, Bucciarelli L, Qu W, Lu Y, Rong LL, Jenkins DG, Stein G, Schmidt AM, Yan SF.
    Atherosclerosis; 2006 Mar; 185(1):70-7. PubMed ID: 16076470
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elovl6 Deficiency Improves Glycemic Control in Diabetic db/db Mice by Expanding β-Cell Mass and Increasing Insulin Secretory Capacity.
    Zhao H, Matsuzaka T, Nakano Y, Motomura K, Tang N, Yokoo T, Okajima Y, Han SI, Takeuchi Y, Aita Y, Iwasaki H, Yatoh S, Suzuki H, Sekiya M, Yahagi N, Nakagawa Y, Sone H, Yamada N, Shimano H.
    Diabetes; 2017 Jul; 66(7):1833-1846. PubMed ID: 28461456
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reduced proliferation and a high apoptotic frequency of pancreatic beta cells contribute to genetically-determined diabetes susceptibility of db/db BKS mice.
    Puff R, Dames P, Weise M, Göke B, Seissler J, Parhofer KG, Lechner A.
    Horm Metab Res; 2011 May; 43(5):306-11. PubMed ID: 21412687
    [Abstract] [Full Text] [Related]

  • 10. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
    Garris DR, Garris BL.
    Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
    [Abstract] [Full Text] [Related]

  • 11. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
    Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y.
    Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
    [Abstract] [Full Text] [Related]

  • 12. Leptin-mediated inflammatory signaling crucially links visceral fat inflammation to obesity-associated β-cell dysfunction.
    Tian YF, Chang WC, Loh CH, Hsieh PS.
    Life Sci; 2014 Oct 22; 116(1):51-8. PubMed ID: 25123537
    [Abstract] [Full Text] [Related]

  • 13. Restoration of Lepr in β cells of Lepr null mice does not prevent hyperinsulinemia and hyperglycemia.
    D'souza AM, Kieffer TJ.
    Mol Metab; 2017 Jun 22; 6(6):585-593. PubMed ID: 28580288
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of miR-153, an IL-1β-responsive miRNA, prevents beta cell failure and inflammation-associated diabetes.
    Sun Y, Zhou S, Shi Y, Zhou Y, Zhang Y, Liu K, Zhu Y, Han X.
    Metabolism; 2020 Oct 22; 111():154335. PubMed ID: 32795559
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Harrity T, Farrelly D, Tieman A, Chu C, Kunselman L, Gu L, Ponticiello R, Cap M, Qu F, Shao C, Wang W, Zhang H, Fenderson W, Chen S, Devasthale P, Jeon Y, Seethala R, Yang WP, Ren J, Zhou M, Ryono D, Biller S, Mookhtiar KA, Wetterau J, Gregg R, Cheng PT, Hariharan N.
    Diabetes; 2006 Jan 22; 55(1):240-8. PubMed ID: 16380499
    [Abstract] [Full Text] [Related]

  • 19. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD, Lavery KS, Irwin N, O'harte FP, Harriott P, Greer B, Bailey CJ, Flatt PR.
    J Pharmacol Exp Ther; 2006 Aug 22; 318(2):914-21. PubMed ID: 16648370
    [Abstract] [Full Text] [Related]

  • 20. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.
    Oakes ND, Thalén P, Aasum E, Edgley A, Larsen T, Furler SM, Ljung B, Severson D.
    Am J Physiol Endocrinol Metab; 2006 May 22; 290(5):E870-81. PubMed ID: 16352676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.